Skip to content

Comparison between platelet rich fibrin membrane and bone marrow aspirate concentrate added to patients of rotator cuff repair A randomized control trial

Comparison of functional outcomes and healing of rotator cuff repairs augmentation between platelet rich fibrin membrane and bone marrow aspirate concentrate -A randomized control trial - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111785
Enrollment
42
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M751- Rotator cuff tear or rupture, notspecified as traumatic

Interventions

Intervention1: PRF membrane augmentation: Rotator cuff repair is done and augmented with PRF membrane 6 months follow up Intervention2: Bone marrow aspirate concentrate: Rotator cuff reapir is done an

Sponsors

VISHWA R B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Complete tear of the rotator cuff tendon diagnosed with magnetic resonance images 2. Symptomatic for rotator cuff tear, including pain and weakness 3. Age more than 18 years 4.Either gender

Exclusion criteria

Exclusion criteria: 1. History of shoulder surgery within 3 months. 2. Presence of osteophyte or bony deformity, rotator cuff arthropathy on radiographs 3. Partial tear of the rotator cuff tendon. 4. Brachial plexus injuries 5. Presence Of abnormality in blood coagulation, complete Blood count, or blood chemistry, 6. Positive urine pregnancy test in case of fertile woman. 7. Patients not willing for surgery 8. History of steroid injection during the past 3 months. 9. Patients who cannot comply with postoperative rehabilitation protocol, such as neuropsychiatric illnesses.

Design outcomes

Primary

MeasureTime frame
the functional outcomes (ASES, Constant murley score, and VAS Score) and healing rates (Sugaya classification) following RCR augmented with PRF membrane or BMAC.Timepoint: 6 months after surgery

Secondary

MeasureTime frame
To measure the retear rates among RCR augmentation with PRF and BMAC.Timepoint: 6 months after surgery; To determine association between tear characteristics like chronicity, retraction and fatty atrophy with healing rates in the two groups.Timepoint: 6 months after surgery

Countries

India

Contacts

Public ContactDR TARUN GOYAL

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

goyal.tarun@gmail.com8475000283

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026